# Opinion: Why Are We Not Talking About Cannabis in Clinical Care?

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-clinical-discourse-why-we-must-talk-about-weed/
> **Published:** 2026-04-25T01:47:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:02:31-04:00
> **Clinical Summary:** Explore the importance of cannabis clinical discourse for healthcare providers to improve patient care and safety in the evolving cannabis landscape.

---

✦ New

 CED Clinical Relevance
 #8
 Clinical Context
 Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape.

PolicyMental HealthIndustry

 Clinical Summary

# Clinical Summary

This opinion piece addresses the apparent reluctance among healthcare providers and policymakers to engage in substantive discussions about cannabis use and its role in [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) despite increasing legalization and use. The article emphasizes that avoidance of cannabis conversations leaves clinicians and patients without evidence-based guidance on efficacy, safety, and appropriate use, potentially contributing to suboptimal health outcomes. By framing cannabis as a topic requiring open clinical discourse, the piece argues that healthcare professionals have a responsibility to educate themselves and patients about [cannabinoid pharmacology](https://cedclinic.com/cannabinoid-drug-interactions-clinical-evidence/), potential therapeutic applications, and risks including drug interactions and contraindications. The broader public health concern is that silence on cannabis perpetuates knowledge gaps that may lead to unsafe use patterns, particularly among vulnerable populations who might benefit from qualified medical oversight. Clinicians should recognize that patient cannabis use is prevalent and increasingly frequent, making informed discussion during clinical encounters essential for comprehensive medication reconciliation and harm reduction counseling.

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Opinion%3A%20Why%20are%20we%20not%20talking%20about%20weed%3F%20%7C%20Calgary%20Herald%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fopinion-why-are-we-not-talking-about-weed-calgary-herald%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fopinion-why-are-we-not-talking-about-weed-calgary-herald%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Opinion%3A%20Why%20are%20we%20not%20talking%20about%20weed%3F%20%7C%20Calgary%20Herald%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fopinion-why-are-we-not-talking-about-weed-calgary-herald%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Citywide Art and History Exhibitions – City of Aurora](https://cedclinic.com/citywide-art-and-history-exhibitions-city-of-aurora/)

Explore cultural events that shape community perspectives, including evolving views on [cannabis and public health](https://cedclinic.com/illicit-drug-use-dependence-global-burden/).

[Discover More](https://cedclinic.com/citywide-art-and-history-exhibitions-city-of-aurora/)

[The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/)

Learn about [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) that support health and wellness, complementing informed cannabis clinical care.

[Learn More](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/)

[Bemidji Chamber Ambassadors welcome Coconut Cannabis](https://cedclinic.com/bemidji-chamber-ambassadors-welcome-coconut-cannabis/)

Discover community engagement with cannabis businesses promoting education and responsible use.

[Read More](https://cedclinic.com/bemidji-chamber-ambassadors-welcome-coconut-cannabis/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).